| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |